Aurora Cannabis Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

Aurora Cannabis hat ein Gesamteigenkapital von CA$583.0M und eine Gesamtverschuldung von CA$57.5M, was einen Verschuldungsgrad von 9.9% ergibt. Die Gesamtaktiva und Gesamtpassiva betragen CA$808.8M bzw. CA$225.8M.

Wichtige Informationen

9.9%

Verhältnis von Schulden zu Eigenkapital

CA$57.51m

Verschuldung

Zinsdeckungsgrad	n/a
Bargeld	CA$84.92m
Eigenkapital	CA$582.97m
Gesamtverbindlichkeiten	CA$225.80m
Gesamtvermögen	CA$808.77m

Jüngste Berichte zur Finanzlage

Keine Aktualisierungen

Recent updates

Aurora Cannabis: Revving Up To Profitability

Aug 08

Aurora launches new cannabis products for adult and medical-use

Oct 17

Aurora Cannabis further strengthens its balance sheet by repurchasing ~US$23M of convertible notes

Oct 07

Is Aurora Cannabis Stock A Buy Or Sell Before Upcoming Earnings? Buy The U.S. Opportunity

Sep 16

Aurora Cannabis Is A Pass For Now, Although We Are Bullish On The Industry

Jun 05

Aurora Cannabis: Extreme Downside Case Averted

Feb 02

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: ACBDie kurzfristigen Aktiva des Unternehmens (CA$417.7M) übersteigen seine kurzfristigen Passiva (CA$109.1M).

Langfristige Verbindlichkeiten: ACBDie kurzfristigen Vermögenswerte des Unternehmens (CA$417.7M) übersteigen seine langfristigen Verbindlichkeiten (CA$116.7M).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: ACB über mehr Barmittel verfügt als seine Gesamtverschuldung.

Schulden abbauen: ACB Das Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 15.7% auf 9.9% zurückgegangen.

Bilanz

Liquiditätsreserve-Analyse

Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.

Stabile Start- und Landebahn für Bargeld: ACB auf der Grundlage seines derzeitigen freier Cashflows über eine ausreichende Liquiditätsreserve für mehr als ein Jahr verfügt.

Vorhersage Cash Runway: Unzureichende Daten, um festzustellen, ob ACB über genügend Cash Runway verfügt, wenn sein freier Cashflow auf der Grundlage historischer Raten weiter wächst oder schrumpft.

Aurora Cannabis Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Recent updates

Aurora Cannabis Inc. Expands Innovative Recreational Product Portfolio

New minor risk - Profitability

Forecast to breakeven in 2026

Aurora Cannabis Inc. Announces Notice of Proposed Settlement of Class Action Involving All Persons and Entities Who Purchased Aurora Cannabis Inc. Common Stock Between October 23, 2018 and February 28, 2020, Inclusive

Second quarter 2025 earnings released: EPS: CA$0.05 (vs CA$0.048 in 2Q 2024)

Aurora Cannabis Inc. to Report Q2, 2025 Results on Nov 06, 2024

Aurora Cannabis Inc. Announces Board Changes and Changes to Board Committee Compositions

First quarter 2025 earnings: EPS and revenues exceed analyst expectations

Aurora Cannabis: Revving Up To Profitability

Aurora Cannabis Inc. to Report Q1, 2025 Results on Aug 07, 2024

New minor risk - Profitability

Full year 2024 earnings released: CA$1.28 loss per share (vs CA$8.22 loss in FY 2023)

Forecast breakeven date pushed back to 2027

Aurora Cannabis Inc. Appoints Rajesh Uttamchandani to its Board of Directors

Aurora Cannabis Inc. in Conjunction with MedReleaf Australia, Announce Expansion of its Portfolio with Introduction of New Range of Premium Dried Cannabis Flower Products

New minor risk - Share price stability

Aurora Cannabis Inc. Announces CFO Changes

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

New major risk - Shareholder dilution

New minor risk - Profitability

Aurora Cannabis Inc. (TSX:ACB) acquired remaining 90% stake in Indica Industries Pty Ltd for AUD 45 million.

Aurora Cannabis Inc. Provides Earnings Guidance for the Fourth Quarter of Fiscal 2024

Aurora Cannabis Inc. to Report Q3, 2024 Results on Feb 08, 2024

Forecast to breakeven in 2026

New major risk - Financial position

Aurora Cannabis Inc. Provides Revenue Guidance for Third Quarter of Fiscal 2024

Aurora Cannabis Inc. to Report Q2, 2024 Results on Nov 09, 2023

New major risk - Shareholder dilution

Aurora Cannabis Inc. has completed a Follow-on Equity Offering in the amount of CAD 38.826875 million.

New major risk - Financial position

Aurora Cannabis Inc. Provides Revenue Guidance for the Second Quarter of Fiscal Year 2024

Aurora Cannabis Inc. to Report Q1, 2024 Results on Aug 10, 2023

Bevo Farms Ltd acquired Medicine Hat, Alberta Aurora Sun Facility from Aurora Cannabis Inc. (TSX:ACB) for CAD 15 million.

Now 21% undervalued after recent price drop

CEO & Director recently bought US$98k worth of stock

New minor risk - Profitability

Third quarter 2023 earnings released: CA$0.24 loss per share (vs CA$4.72 loss in 3Q 2022)

Aurora Cannabis Inc. to Report Fiscal Year 2023 Results on Jun 14, 2023

Aurora Celebrates Summer with New Innovation Launching Across Canada

Aurora Cannabis Inc., Annual General Meeting, Aug 14, 2023

Forecast to breakeven in 2026

Aurora Cannabis Inc. Reports Impairment Changes for the Quarter Ended December 31, 2022

Second quarter 2023 earnings released

Aurora Cannabis Inc. to Report Q2, 2023 Results on Feb 09, 2023

An Unknown buyer acquired Aurora Polaris facility from Aurora Cannabis Inc. for CAD15 million.

Now 20% undervalued after recent price drop

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Forecast to breakeven in 2025

First quarter 2023 earnings released: CA$0.17 loss per share (vs CA$0.06 loss in 1Q 2022)

Aurora Cannabis Inc. to Report Q1, 2023 Results on Nov 10, 2022

Aurora Announces Unprecedented Fall Product Release Across Adult-Use and Medical Markets

Aurora Announces Unprecedented Fall Product Release Across Adult-Use and Medical Markets

Aurora launches new cannabis products for adult and medical-use

Aurora Cannabis further strengthens its balance sheet by repurchasing ~US$23M of convertible notes

Full year 2022 earnings: Revenues in line with analyst expectations

Aurora Cannabis Q4 2022 Earnings Preview

Aurora Cannabis Inc. to Report Q4, 2022 Results on Sep 20, 2022

Aurora Cannabis Inc., Annual General Meeting, Nov 14, 2022

Aurora Cannabis Inc. (TSX:ACB) acquired 50.1% stake in Bevo Agtech Inc. for CAD 57 million.

Aurora Cannabis: Don't Let Your Money Go Up In Smoke

Why Did Aurora Cannabis Stock Crash In May; Can It Recover?

Independent Director recently bought US$66k worth of stock

Aurora Cannabis Inc. has completed a Composite Units Offering in the amount of $150.00125 million.

Aurora Cannabis Inc. has completed a Composite Units Offering in the amount of $125.195 million.

Aurora Cannabis Inc. Reports Impairment Chargers for the Three Months Ended March 31, 2022

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Recent Developments Do Not Change Our Stance On Aurora Cannabis

Aurora Cannabis Inc. (TSX:ACB) completed the acquisition of TerraFarma, Inc. for CAD 38 million.

Aurora Cannabis: A Train Wreck Desperate For Help

Aurora Cannabis Inc. to Report Q3, 2022 Results on May 12, 2022

High number of new directors

Aurora Cannabis: The Fallen Pot Giant That Still Can't Find Its Way

An unknown buyer entered into an asset purchase agreement to acquire Nordic Sky Production Facility located in Denmark from Aurora Cannabis Inc. (TSX:ACB) for CAD 7.5 million.

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

High number of new directors